In addition to RAS-dependency in the correlation between SIRT1 expression and OS of cancer patients as shown in Figure 1F, this further suggests that SIRT1 can act as a more potent tumor suppressor particularly in RAS-driven tumorigenesis. This evidence concerns the gene SIRT1 and neoplasm.